GLP-1 medications like Ozempic and Mounjaro can influence the volume of all-cause hospital admissions and bariatric surgeries, two studies suggest. Researchers at Boston-based Harvard Medical School ...
The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...